Congenital Adrenal Hyperplasia due to 3β-Hydroxysteroid Dehydrogenase/ Δ⁵-Δ⁴ Isomerase Deficiency

 

 Buy Article Permissions and Reprints

ABSTRACT

The 3β-hydroxysteroid dehydrogenase/Δ⁵-Δ ⁴ isomerase (3β-HSD) isoenzymes are responsible for the oxidation and isomerization of Δ⁵-3β-hydroxysteroid precursors into Δ⁴-ketosteroids, thus catalyzing an essential step in the formation of all classes of active steroid hormones. The 3β-HSD gene family should have evolved to facilitate differential patterns of tissue- and cell-specific expression and regulation involving multiple signal transduction pathways, which are activated by several growth factors, steroids, and cytokines. In humans, there are two 3β-HSD isoenzymes, which were chronologically designated type I and II encoded by HSD3B1 and HSD3B2 gene, respectively. HSD3B1 gene encodes the almost exclusive 3β-HSD isoenzyme expressed in the placenta and peripheral tissues, whereas HSD3B2 gene encodes the predominant 3β-HSD isoenzyme expressed in the adrenal gland, ovary, and testis and its deficiency is responsible for a rare form of congenital adrenal hyperplasia causing various degrees of salt-wasting in both sexes and incomplete masculinization of the external genitalia in genetic males. Although an elevated ratio of Δ⁵-/Δ ⁴ -steroids was considered to be the best biological parameter for the diagnosis of this autosomal recessive disorder, the most accurate criteria now appears to be the plasma levels of 17-OH-pregnenolone greater than 100 nmol/L following ACTH stimulation. To date a total of 34 mutations (including 5 frameshift, 4 nonsense, 1 in-frame deletion, 1 splicing, and 23 missense mutations) have been identified in the HSD3B2 gene in 56 individuals from 44 families suffering from classical 3β-HSD deficiency. In almost all the cases, the functional characterization of HSD3B2 mutations has provided a molecular explanation for the heterogeneous clinical presentation of this disorder. Indeed these experiments confirm that no functional 3βHSD type II isoenzyme is expressed in the adrenals and gonads of the patients suffering from a severe salt-wasting form, whereas the non-salt-losing form results from specific missense mutation(s) in the HSD3B2 gene, which causes an incomplete loss of enzymatic activity thus leaving sufficient enzymatic activity to prevent salt wasting. Moreover, various mutations appear to have a drastic effect upon stability of the protein, therefore providing molecular evidence of a new mechanism involved in classical 3β-HSD deficiency. Thus, the elucidation of the molecular basis of 3β-HSD deficiency has highlighted the fact that mutations in the HSD3B2 gene can result in a wide spectrum of molecular repercussions, which are associated with the different phenotypic manifestations of classical 3β-HSD deficiency and also provide valuable information concerning the structure-function relationships of the 3β-HSD superfamily.

REFERENCES

• 1 Cherradi N, Defaye G, Chambaz E M. Dual subcellular localization of the 3β-hydroxysteroid dehydrogenase isomerase: characterization of the mitochondrial enzyme in the bovine adrenal cortex.  J Steroid Biochem Mol Biol . 1993;  46 773-779
  CrossrefPubMedGoogle Scholar
• 2 Cherradi N, Defaye G, Chambaz E M. Characterization of the 3β-hydroxysteroid dehydrogenase activity associated with bovine adrenocortical mitochondria.  Endocrinology . 1994;  134 1358-1364
  CrossrefPubMedGoogle Scholar
• 3 Cherradi N, Rossier M F, Vallotton M B. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome p450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells.  J Biol Chem . 1997;  272 7899-7907
  CrossrefPubMedGoogle Scholar
• 4 Luu-The V, Lachance Y, Labrie C. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase.  Mol Endocrinol . 1989;  3 1310-1312
  PubMedGoogle Scholar
• 5 Sauer L A, Chapman J C, Dauchy R T. Topology of 3β-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in adrenal cortex mitochondria and microsomes.  Endocrinology . 1994;  134 751-759
  CrossrefPubMedGoogle Scholar
• 6 Thomas J L, Evans B W, Blanco G. Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3β-hydroxysteroid dehydrogenase/isomerase.  J Steroid Biochem Mol Biol . 1998;  66 327-334
  CrossrefPubMedGoogle Scholar
• 7 Mason J I, Keeney D S, Bird I M. The regulation of 3β-hydroxysteroid dehydrogenase expression.  Steroids . 1997;  62 164-168
  CrossrefPubMedGoogle Scholar
• 8 Payne A H, Abbaszade I G, Clarke T R, Bain P A, Park C H. The multiple murine 3β-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression.  Steroids . 1997;  62 169-175
  CrossrefPubMedGoogle Scholar
• 9 Simard J, Durocher F, Mebarki F. Molecular biology and genetics of the 3β-hydroxysteroid dehydrogenase/ delta5-delta4 isomerase gene family.  J Endocrinol . 1996;  150(suppl) S189-S207
  PubMedGoogle Scholar
• 10 Mason J I, Naville D, Evans B W, Thomas J L. Functional activity of 3β-hydroxysteroid dehydrogenase/isomerase.  Endocr Res . 1998;  24 549-557
  PubMedGoogle Scholar
• 11 Lachance Y, Luu-The V, Labrie C. Characterization of human 3β-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells [published erratum appears in J Biol Chem 1992;267:3551].  J Biol Chem . 1990;  265 20469-20475
  PubMedGoogle Scholar
• 12 Lorence M C, Murry B A, Trant J M, Mason J I. Human 3β-hydroxysteroid dehydrogenase/delta 5-4 isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids.  Endocrinology . 1990;  126 2493-2498
  CrossrefPubMedGoogle Scholar
• 13 Rheaume E, Lachance Y, Zhao H F. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.  Mol Endocrinol . 1991;  5 1147-1157
  PubMedGoogle Scholar
• 14 Thomas J L, Frieden C, Nash W E, Strickler R C. An NADH-induced conformational change that mediates the sequential 3β-hydroxysteroid dehydrogenase/isomerase activities is supported by affinity labeling and the time-dependent activation of isomerase.  J Biol Chem . 1995;  270 21003-21008
  CrossrefPubMedGoogle Scholar
• 15 Luu-The V, Coté J, Labrie F. 1988 Purification and characterization of human placental 3β-hydroxysteroid dehydrogenase/5-4-isomerase (Abstract).  Clin Invest Med . 1988;  11(suppl) C32
  PubMedGoogle Scholar
• 16 Luu-The V, Coté J, Labrie F. 1990 Purification of microsomal 3β-hydroxysteroid dehydrogenase/5-4-isomerase from human placenta.  Ann N Y Acad Sci . 1990;  595 386-388
  PubMedGoogle Scholar
• 17 Nickson D A, McBride M W, Zeinali S. Molecular cloning and expression of human trophoblast antigen FDO161G and its identification as 3β-hydroxy-5-ene steroid dehydrogenase.  J Reprod Fertil . 1991;  93 149-156
  PubMedGoogle Scholar
• 18 Dumont M, Van L T, Dupont E, Pelletier G, Labrie F. Characterization, expression, and immunohistochemical localization of 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin.  J Invest Dermatol . 1992;  99 415-421
  CrossrefPubMedGoogle Scholar
• 19 Gingras S, Moriggl R, Groner B, Simard J. Induction of 3β-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.  Mol Endocrinol . 1999;  13 66-81
  CrossrefPubMedGoogle Scholar
• 20 Gingras S, Simard J. Induction of 3β-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.  Endocrinology . 1999;  140 4573-4584
  CrossrefPubMedGoogle Scholar
• 21 Lachance Y, Luu-The V, Labrie C. Characterization of human 3β-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells [erratum].  J Biol Chem . 1992;  267 3551
  PubMedGoogle Scholar
• 22 Rheaume E, Simard J, Morel Y. Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene.  Nat Genet . 1992;  1 239-245
  PubMedGoogle Scholar
• 23 Simard J, Rheaume E, Mebarki F. Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency.  J Steroid Biochem Mol Biol . 1995;  53 127-138
  CrossrefPubMedGoogle Scholar
• 24 Simard J, Rheaume E, Sanchez R. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency.  Mol Endocrinol . 1993;  7 716-728
  CrossrefPubMedGoogle Scholar
• 25 Lachance Y, Luu-The V, Verreault H. Structure of the human type II 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3β-HSD) gene: adrenal and gonadal specificity.  DNA Cell Biol . 1991;  10 701-711
  CrossrefPubMedGoogle Scholar
• 26 Lorence M C, Corbin C J, Kamimura N, Mahendroo M S, Mason J I. Structural analysis of the gene encoding human 3β-hydroxysteroid dehydrogenase/delta 5-4-isomerase.  Mol Endocrinol . 1990;  4 1850-1855
  CrossrefPubMedGoogle Scholar
• 27 Berube D, Luu-The V, Lachance Y, Gagne R, Labrie F. Assignment of the human 3β-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1.  Cytogenet Cell Genet . 1989;  52 199-200
  PubMedGoogle Scholar
• 28 Morissette J, Rheaume E, Leblanc J F. Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and II 3β-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase close to D1S514 and the centromeric D1Z5 locus.  Cytogenet Cell Genet . 1995;  69 59-62
  PubMedGoogle Scholar
• 29 Luu-The V, Lachance Y, Leblanc G, Labrie F. Human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase: characterization of three additional related genes. Proceedings of the 74th Annual Endocrine Society Meeting, San Antonio, June 1992
  Google Scholar
• 30 Bain P A, Meisler M H, Taylor B A, Payne A H. The genes encoding gonadal and nongonadal forms of 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase are closely linked on mouse chromosome 3.  Genomics . 1993;  16 219-223
  CrossrefPubMedGoogle Scholar
• 31 McBride M W, McVie A J, Burridge S M. Cloning, expression, and physical mapping of the 3β-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human.  Genomics . 1999;  61 277-284
  CrossrefPubMedGoogle Scholar
• 32 Russell A, Nazer H, Shams A, Sjovall J, Sutcliffe R. No linkage to the 3β-HSD gene cluster in a kindred affected with 3β-hydroxy-delta 5-C27-steroid dehydrogenase deficiency and early onset hepatic failure.  Hum Genet . 1995;  95 586-588
  PubMedGoogle Scholar
• 33 Furster C. Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-delta 5-C27-steroid dehydrogenase in pig tissues and subcellular fractions.  Biochim Biophys Acta . 1999;  1436 343-353
  PubMedGoogle Scholar
• 34 Filling C, Marschall H U, Prozorovski T. Structure-function relationships of 3β-hydroxysteroid dehydrogenases involved in bile acid metabolism.  Adv Exp Med Biol . 1999;  463 389-394
  PubMedGoogle Scholar
• 35 Liu X Y, Dangel A W, Kelley R I. The gene mutated in bare patches and striated mice encodes a novel 3β-hydroxysteroid dehydrogenase.  Nat Genet . 1999;  22 182-187
  PubMedGoogle Scholar
• 36 Wilson J D, Griffin J E, Russell D W. Steroid 5 alpha-reductase 2 deficiency.  Endocr Rev . 1993;  14 577-593
  CrossrefPubMedGoogle Scholar
• 37 Grumbach M, Conte F. Disorders of sex differentiation. In: Wilson JD, et al, eds. Williams Textbook of Endocrinology Philadelphia: WB Saunders 1999: 1303-1425
  Google Scholar
• 38 Quigley C A. Disorders of sex determination and differentiation. In: Jameson JL, ed. Principles of Molecular Medicine Totowa, NJ: Humana Press 1998: 527-559
  Google Scholar
• 39 Dupont E, Labrie F, Luu-The V, Pelletier G. Immunocytochemical localization of 3β-hydroxysteroid dehydrogenase/ delta 5-delta 4-isomerase in human ovary.  J Clin Endocrinol Metab . 1992;  74 994-998
  CrossrefPubMedGoogle Scholar
• 40 Kaplan S, Grumbach M. Pituitary and placental gonadotropin and sex steroids in the human and sub-human primate fetus.  J Clin Endocrinol Metab . 1978;  7 487-511
  PubMedGoogle Scholar
• 41 Goldman A S, Yakovac W C, Bongiovanni A M. Development of activity of 3β-hydroxysteroid dehydrogenase in human fetal tissues and in two anencephalic newborns.  J Clin Endocrinol Metab . 1966;  26 14-22
  PubMedGoogle Scholar
• 42 George F W, Wilson J D. The regulation of androgen and estrogen formation in fetal gonads.  Ann Biol Anim Biochem Biophys . 1979;  19 1297-1306
  PubMedGoogle Scholar
• 43 Baillie A, Niemi M, Ikanen M. 3β-Hydroxysteroid dehydrogenase activity in the human foetal testis.  Acta Endocrinol (Copenh) . 1965;  48 429-438
  PubMedGoogle Scholar
• 44 Milewich L, Shaw C E, Doody K M. 3β-Hydroxysteroid dehydrogenase activity in glandular and extraglandular human fetal tissues.  J Clin Endocrinol Metab . 1991;  73 1134-1140
  PubMedGoogle Scholar
• 45 Parker Jr R C, Faye-Petersen O, Stankovic A K, Mason J I, Grizzle W E. Immunohistochemical evaluation of the cellular localization and ontogeny of 3β-hydroxysteroid dehydrogenase/delta 5-4 isomerase in the human fetal adrenal gland.  Endocr Res . 1995;  21 69-80
  PubMedGoogle Scholar
• 46 Dupont E, Luu-The V, Labrie F, Pelletier G. Ontogeny of 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3β-HSD) in human testis as studied by immunocytochemistry.  J Androl . 1991;  12 161-164
  PubMedGoogle Scholar
• 47 Seron Ferre M. Steroid production by definitive and fetal zones of the human fetal adrenal gland.  J Clin Endocrinol Metab . 1978;  47 603-609
  PubMedGoogle Scholar
• 48 Simonian M H, Gill G N. Regulation of the fetal human adrenal cortex: effects of adrenocorticotropin on growth and function of monolayer cultures of fetal and definitive zone cells.  Endocrinology . 1981;  108 1769-1779
  PubMedGoogle Scholar
• 49 Dupont E, Luu-The V, Labrie F, Pelletier G. Ontogeny of 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3β-HSD) in human adrenal gland performed by immunocytochemistry.  Mol Cell Endocrinol . 1990;  74 R7-R10
  CrossrefPubMedGoogle Scholar
• 50 Doody K M, Carr B R, Rainey W E. 3β-Hydroxysteroid dehydrogenase/isomerase in the fetal zone and neocortex of the human fetal adrenal gland.  Endocrinology . 1990;  126 2487-2492
  CrossrefPubMedGoogle Scholar
• 51 Mesiano S, Coulter C L, Jaffe R B. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17,20-lyase, and 3β-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation.  J Clin Endocrinol Metab . 1993;  77 1184-1189
  CrossrefPubMedGoogle Scholar
• 52 Voutilainen R, Ilvesmaki V, Miettinen P J. Low expression of 3β-hydroxy-5-ene steroid dehydrogenase gene in human fetal adrenals in vivo: adrenocorticotropin and protein kinase C-dependent regulation in adrenocortical cultures.  J Clin Endocrinol Metab . 1991;  72 761-767
  PubMedGoogle Scholar
• 53 Dupont E, Luu-The V, Labrie F, Pelletier G. Light microscopic immunocytochemical localization of 3β-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in the gonads and adrenal glands of the guinea pig.  Endocrinology . 1990;  126 2906-2909
  PubMedGoogle Scholar
• 54 Albrecht E D, Aberdeen G W, Babischkin J S, Tilly J L, Pepe G J. Biphasic developmental expression of adrenocorticotropin receptor messenger ribonucleic acid levels in the baboon fetal adrenal gland.  Endocrinology . 1996;  137 1292-1298
  CrossrefPubMedGoogle Scholar
• 55 Coulter C L, Goldsmith P C, Mesiano S. Functional maturation of the primate fetal adrenal in vivo: II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3β-hydroxysteroid dehydrogenase/isomerase.  Endocrinology . 1996;  137 4953-4959
  CrossrefPubMedGoogle Scholar
• 56 Herman-Giddens M E, Slora E, Wasserman R C. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network.  Pediatrics . 1997;  99 505-512
  CrossrefPubMedGoogle Scholar
• 57 Cutler Jr B G, Glenn M, Bush M. Adrenarche: a survey of rodents, domestic animals, and primates.  Endocrinology . 1978;  103 2112-2118
  PubMedGoogle Scholar
• 58 Dardis A, Saraco N, Rivarola M A, Belgorosky A. Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: implications for the mechanism of adrenarche.  Pediatr Res . 1999;  45 384-388
  PubMedGoogle Scholar
• 59 Gell J S, Carr B R, Sasano H. Adrenarche results from development of a 3β-hydroxysteroid dehydrogenase- deficient adrenal reticularis.  J Clin Endocrinol Metab . 1998;  83 3695-3701
  CrossrefPubMedGoogle Scholar
• 60 Conley A J, Bird I M. The role of cytochrome P450 17 alpha-hydroxylase and 3β-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals.  Biol Reprod . 1997;  56 789-799
  CrossrefPubMedGoogle Scholar
• 61 Mapes S, Corbin C J, Tarantal A, Conley A. The primate adrenal zona reticularis is defined by expression of cytochrome b5, 17alpha-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3β-hydroxysteroid dehydrogenase/delta5-4 isomerase (3β-HSD).  J Clin Endocrinol Metab . 1999;  84 3382-3385
  CrossrefPubMedGoogle Scholar
• 62 Miller W. The regulation of 17,20 lyase activity.  Steroids . 1997;  62 133-142
  CrossrefPubMedGoogle Scholar
• 63 Bois E, Mornet E, Chompret A. Congenital adrenal hyperplasia (21-OH) in France: population genetics.  Arch Fr Pediatr . 1985;  42 175-179
  PubMedGoogle Scholar
• 64 Thilen A, Larsson A. Congenital adrenal hyperplasia in Sweden 1969-1986; prevalence, symptoms and age at diagnosis.  Acta Paediatr Scand . 1990;  79 168-175
  PubMedGoogle Scholar
• 65 Donohoue P, Parker K, Migeon C. Congenital adrenal hyperplasia. In: Scriver C, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease New York: Mc-Graw-Hill 1995: 2929-2966
  Google Scholar
• 66 Forest M G. Diagnosis and treatment of disorders of sexual development. In: Degroot LJ, ed. Endocrinology 3rd ed. Vol. 2. Montreal: WB Saunders 1995: 1901-1937
  Google Scholar
• 67 Wilson R, New M I. Congenital adrenal hyperplasia. In: Jameson JL, ed. Principles of Molecular Medicine Totowa, NJ: Humana Press 1998: 481-493
  Google Scholar
• 68 Bongiovanni A M. Unusual steroid pattern in congenital adrenal hyperplasia: deficiency of 3β-hydroxysteroid dehydrogenase.  J Clin Endocrinol . 1961;  21 860-862
  PubMedGoogle Scholar
• 69 Bongiovanni A M. The adrenogenital syndrome with deficiency of 3b-hydroxy dehydrogenase.  J Clin Invest . 1962;  41 2086-2092
  CrossrefPubMedGoogle Scholar
• 70 Moisan A M, Ricketts M L, Tardy V. New insight into the molecular basis of 3β-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.  J Clin Endocrinol Metab . 1999;  84 4410-4425
  CrossrefPubMedGoogle Scholar
• 71 Morel Y, Mebarki F, Rheaume E. Structure-function relationships of 3β-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3β-hydroxysteroid dehydrogenase deficiency.  Steroids . 1997;  62 176-184
  CrossrefPubMedGoogle Scholar
• 72 Pang S. The molecular and clinical spectrum of 3β-hydroxysteroid dehydrogenase deficiency disorder.  Trends Endocrinol Metab . 1998;  9 82-86
  PubMedGoogle Scholar
• 73 Russell A J, Wallace A M, Forest M G. Mutation in the human gene for 3β-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss.  J Mol Endocrinol . 1994;  12 225-237
  PubMedGoogle Scholar
• 74 Eldar-Geva T, Hurwitz A, Vecsei P. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia.  N Engl J Med . 1990;  323 855-863
  PubMedGoogle Scholar
• 75 Medina M, Herrera J, Flores M. Normal ovarian function in a mild form of late-onset 3β-hydroxysteroid dehydrogenase deficiency.  Fertil Steril . 1986;  46 1021-1025
  PubMedGoogle Scholar
• 76 Pang S Y, Lerner A J, Stoner E. Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency: I. A cause of hirsutism in pubertal and postpubertal women.  J Clin Endocrinol Metab . 1985;  60 428-439
  PubMedGoogle Scholar
• 77 Schram P, Zerah M, Mani P. Nonclassical 3β-hydroxysteroid dehydrogenase deficiency: a review of our experience with 25 female patients.  Fertil Steril . 1992;  58 129-136
  PubMedGoogle Scholar
• 78 Zerah M, Rheaume E, Mani P. No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3βHSD) in nonclassical 3βHSD deficiency.  J Clin Endocrinol Metab . 1994;  79 1811-1817
  CrossrefPubMedGoogle Scholar
• 79 Chang Y T, Zhang L, Alkaddour H S. Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity.  Pediatr Res . 1995;  37 820-824
  PubMedGoogle Scholar
• 80 Forest M G, Mebatki F, David A, Bureau L, Morel Y. Diagnosis of partial 3β-hydroxysteroid dehydrogenase (3β-HSD) questioned: lessons from long-term study and molecular biology.  Horm Res . 1995;  44 55
  PubMedGoogle Scholar
• 81 Sakkal-Alkaddour H, Zhang L, Yang X. Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.  J Clin Endocrinol Metab . 1996;  81 3961-3965
  CrossrefPubMedGoogle Scholar
• 82 Mebarki F. Etude moléculaire de causes de pseudohermaphrodisme masculin le syndrome d'insensibilité aux androgenes, le deficit en enzyme de la stériodogénese 3β-HSD [doctorat].  Lyon, France: l'Université Lyon; 1995
  Google Scholar
• 83 Moran C, Knochenhauer E S, Azziz R. Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.  J Endocrinol Invest . 1998;  21 707-720
  PubMedGoogle Scholar
• 84 de Peretti E, Forest M G, Feit J P, David M. Endocrine studies in two children with male pseudohermaphroditism due to 3β-hydroxysteroid dehydrogenase (3β-HSD) defect. In: Genazzani AR, Thijssen JHH, Siiteri PK, eds. Adrenal Androgens New York: Raven Press 1980: 141-145
  Google Scholar
• 85 Heinrich U E, Bettendorf M, Vecsei P. Male pseudohermaphroditism caused by nonsalt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency.  J Steroid Biochem Mol Biol . 1993;  45 83-85
  CrossrefPubMedGoogle Scholar
• 86 Janne O, Perheentupa J, Vihko R. Plasma and urinary steroids in an eight-year-old boy with 3-β-hydroxysteroid dehydrogenase deficiency.  J Clin Endocrinol Metab . 1970;  31 162-165
  PubMedGoogle Scholar
• 87 Kenny F M, Reynolds J W, Green O C. Partial 3-hydroxysteroid dehydrogenase (3β-HSD) deficiency in a family with congenital adrenal hyperplasia: evidence for increasing 3β-HSD activity with age.  Pediatrics . 1971;  48 756-765
  PubMedGoogle Scholar
• 88 Parks G A, Bermudez J A, Anast C S, Bongiovanni A M, New M I. Pubertal boy with the 3β-hydroxysteroid dehydrogenase defect.  J Clin Endocrinol Metab . 1971;  33 269-278
  PubMedGoogle Scholar
• 89 Zachmann M, Vollmin J A, Murset G, Curtius H C, Prader A. Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-β-hydroxysteroid dehydrogenase: case report of a surviving girl and steroid studies.  J Clin Endocrinol Metab . 1970;  30 719-726
  PubMedGoogle Scholar
• 90 Gendrel D, Chaussain J L, Roger M, Job J C. [Congenital adrenal hyperplasia due to blockade of 3-β-hydroxysteroid dehydrogenase].  Arch Fr Pediatr . 1979;  36 647-655
  PubMedGoogle Scholar
• 91 Nahoul K, Perrin C, Leymarie P, Job J C. [Elevated levels of plasma 4-ene steroids in a case of congenital deficiency of 3β-hydroxysteroid dehydrogenase].  Ann Endocrinol . 1989;  50 58-63
  PubMedGoogle Scholar
• 92 Rosenfield R L, Rich B H, Wolfsdorf J I. Pubertal presentation of congenital delta 5-3 β-hydroxysteroid dehydrogenase deficiency.  J Clin Endocrinol Metab . 1980;  51 345-353
  PubMedGoogle Scholar
• 93 Cara J F, Moshang Jr T, Bongiovanni A M, Marx B S. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-β-hydroxysteroid dehydrogenase deficiency.  N Engl J Med . 1985;  313 618-621
  CrossrefPubMedGoogle Scholar
• 94 Mendonca B B, Bloise W, Arnhold I J. Male pseudohermaphroditism due to nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty.  J Steroid Biochem . 1987;  28 669-675
  CrossrefPubMedGoogle Scholar
• 95 Pang S, Levine L S, Stoner E. Nonsalt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.  J Clin Endocrinol Metab . 1983;  56 808-818
  PubMedGoogle Scholar
• 96 Alos N, Moisan A M, Ward L. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3β-hydroxysteroid dehydrogenase deficiency in 46 XX and 46 XY French Canadians: evaluation of gonadal function after puberty.  J Clin Endocrinol Metab . 2000;  85 1968-1974
  CrossrefPubMedGoogle Scholar
• 97 Zachmann M, Forest M G, De Peretti E. 3β-Hydroxysteroid dehydrogenase deficiency: follow-up study in a girl with pubertal bone age.  Horm Res . 1979;  11 292-302
  PubMedGoogle Scholar
• 98 Yoshimoto M, Kawaguchi T, Mori R. Pubertal changes in testicular 3β-hydroxysteroid dehydrogenase activity in a male with classical 3β-hydroxysteroid dehydrogenase deficiency showing spontaneous secondary sexual maturation.  Horm Res . 1997;  48 83-87
  PubMedGoogle Scholar
• 99 Mendonca B B, Russell A J, Vasconcelos-Leite M. Mutation in 3β-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females.  J Mol Endocrinol . 1994;  12 119-122
  PubMedGoogle Scholar
• 100 de Peretti E, Forest M G. Pitfalls in the etiological diagnosis of congenital adrenal hyperplasia in the early neonatal period.  Horm Res . 1982;  16 10-22
  PubMedGoogle Scholar
• 101 Labrie F, Belanger A, Luu-The V. Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues. In: Thijssen J, Nieuwenhuyse H, eds. DHEA: A Comprehensive Review New York: Parthenon Publishing 1999: 69-103
  Google Scholar
• 102 Rosenfield R L, Barmach de Niepomniszsze A, Kenny F M, Genel M. The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3β-hydroxysteroid dehydrogenase deficiency.  J Clin Endocrinol Metab . 1974;  39 370-374
  PubMedGoogle Scholar
• 103 Labrie F. Intracrinology.  Mol Cell Endocrinol . 1991;  78 C113-C118
  CrossrefPubMedGoogle Scholar
• 104 Labrie F, Bélanger A, Cusan L, Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.  J Clin Endocrinol Metab . 1997;  82 2403-2409
  CrossrefPubMedGoogle Scholar
• 105 Labrie F, Belanger A, Cusan L, Gomez J L, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.  J Clin Endocrinol Metab . 1997;  82 2396-2402
  CrossrefPubMedGoogle Scholar
• 106 Martel C, Melner M H, Gagne D, Simard J, Labrie F. Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3β-HSD), 17β-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey.  Mol Cell Endocrinol . 1994;  104 103-111
  CrossrefPubMedGoogle Scholar
• 107 Zhang L, Mason J I, Naiki Y. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3β-hydroxysteroid dehydrogenase (3βHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3βHSD deficiency disorder.  J Clin Endocrinol Metab . 2000;  85 1678-1685
  CrossrefPubMedGoogle Scholar
• 108 Baker M E, Blasco R. Expansion of the mammalian 3β-hydroxysteroid dehydrogenase/plant dihydroflavonol reductase superfamily to include a bacterial cholesterol dehydrogenase, a bacterial UDP-galactose-4-epimerase, and open reading frames in vaccinia virus and fish lymphocystis disease virus.  FEBS Lett . 1992;  301 89-93
  CrossrefPubMedGoogle Scholar
• 109 Rheaume E, Sanchez R, Mebarki F. Identification and characterization of the G15D mutation found in a male patient with 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency: alteration of the putative NAD-binding domain of type II 3β-HSD.  Biochemistry . 1995;  34 2893-2900
  CrossrefPubMedGoogle Scholar
• 110 Lesk A M. NAD-binding domains of dehydrogenases.  Curr Opin Struct Biol . 1995;  5 775-783
  CrossrefPubMedGoogle Scholar
• 111 Scrutton N S, Berry A, Perham R N. Redesign of the coenzyme specificity of a dehydrogenase by protein engineering.  Nature . 1990;  343 38-43
  CrossrefPubMedGoogle Scholar
• 112 Simard J, de Launoit Y, Labrie F. Characterization of the structure-activity relationships of rat types I and II 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase by site-directed mutagenesis and expression in HeLa cells.  J Biol Chem . 1991;  266 14842-14845
  PubMedGoogle Scholar
• 113 Krozowski Z. 11b-Hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily.  Mol Cell Endocrinol . 1992;  84 C25-C31
  CrossrefPubMedGoogle Scholar
• 114 Thomas J L, Nash W E, Myers R P, Crankshaw M W, Strickler R C. Affinity radiolabeling identifies peptides and amino acids associated with substrate binding in human placental 3β-hydroxy-delta(5)-steroid dehydrogenase.  J Biol Chem . 1993;  268 18507-18512
  PubMedGoogle Scholar
• 115 Mebarki F, Sanchez R, Rheaume E. Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3β-hydroxysteroid dehydrogenase gene.  J Clin Endocrinol Metab . 1995;  80 2127-2134
  CrossrefPubMedGoogle Scholar
• 116 Sanchez R, Mebarki F, Rheaume E. Functional characterization of the novel L108W and P186L mutations detected in the type II 3β-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia.  Hum Mol Genet . 1994;  3 1639-1645
  PubMedGoogle Scholar
• 117 Sanchez R, Rheaume E, Laflamme N. Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3b HSD) gene of a female patient with nonsalt-losing 3βHSD deficiency.  J Clin Endocrinol Metab . 1994;  78 561-567
  CrossrefPubMedGoogle Scholar
• 118 Rheaume E, Sanchez R, Simard J. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency.  J Clin Endocrinol Metab . 1994;  79 1012-1018
  CrossrefPubMedGoogle Scholar
• 119 Fisher R, Eades S, Taylor N. Two brothers with congenital adrenal hyperplasia due to partial 3β-hydroxysteroid dehydrogenase deficiency.  Anal Clin Biochem . 1988;  25(suppl) 133-135
  PubMedGoogle Scholar
• 120 Marui S, Torrealba I M, Russell A J, Latronico A C, Sutcliffe R G, Mendonca B B. A novel homozygous nonsense mutations E135* in the type II 3β-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.  Hum Mutat . 1998;  12 139
  CrossrefPubMedGoogle Scholar
• 121 Tajima T, Fujieda K, Nakae J. Molecular analysis of type II 3β-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3β-hydroxysteroid dehydrogenase deficiency.  Hum Mol Genet . 1995;  4 969-971
  PubMedGoogle Scholar
• 122 Simard J, Rheaume E, Leblanc J F. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3β-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/ Pakistani origin.  Hum Mol Genet . 1994;  3 327-330
  PubMedGoogle Scholar
• 123 Zhang L, Sakkal-Alkaddour H, Chang Y T, Yang X, Pang S. A new compound heterozygous frameshift mutation in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene causes salt-wasting 3β-HSD deficiency congenital adrenal hyperplasia.  J Clin Endocrinol Metab . 1996;  81 291-295
  CrossrefPubMedGoogle Scholar
• 124 Sutcliffe R G, Russell A J, Edwards C R, Wallace A M. Human 3β-hydroxysteroid dehydrogenase: genes and phenotypes.  J Mol Endocrinol . 1996;  17 1-5
  CrossrefPubMedGoogle Scholar
• 125 Marui S, Castro M, Latronico A C. Mutations in type II 3β-Hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.  Clin Endocrinol (Oxf) . 2000;  52 67-75
  CrossrefPubMedGoogle Scholar
• 126 Chang Y, Wang J, Pang S. Molecular basis of the type II 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) gene in patients with non-classic (late-onset) 3β-HSD deficiency congenital adrenal hyperplasia (CAH). Presented at the 75th Annual Endocrine Society Meeting, Las Vegas, June 1993
  Google Scholar
• 127 Nayak S, Lee P A, Witchel S F. Variants of the type II 3β-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents.  Mol Genet Metab . 1998;  64 184-192
  CrossrefPubMedGoogle Scholar
• 128 Tajima T, Nishi Y, Takase A. No genetic mutation in type II 3β-hydroxysteroid dehydrogenase gene in patients with biochemical evidence of enzyme deficiency.  Horm Res . 1997;  47 49-53
  PubMedGoogle Scholar
• 129 LaFont M. Le déficit en 3β-ol-déshydrogénase chez l'enfant [Ph.D  thesis]. Lyon, France: Université Claude-Bernard-Lyon I; 1984
  Google Scholar
• 130 Zachmann M, Kempken B, Anner I, Pezzoli V. Age-related differences in the excretion of delta 5 steroids (D5S) in two related girls with 3β-hydroxysteroid dehydrogenase deficiency.  Pediatr Res . 1988;  24 543
  PubMedGoogle Scholar
• 131 Park O K, Mayo K E. Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge.  Mol Endocrinol . 1991;  5 967-978
  PubMedGoogle Scholar
• 132 Katsumata N, Tanae A, Yasunaga T. A novel missense mutation in the type II 3β-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency.  Hum Mol Genet . 1995;  4 745-746
  PubMedGoogle Scholar
• 133 Yoshimoto M, Baba T, Yokoo T. Case of salt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency: the first Japanese patient.  Acta Paediatr Jpn . 1988;  92 1964-1970
  PubMedGoogle Scholar
• 134 Van Seters P A, Degenhart H, Moolenaar A J. Biochemical concealment of 3βHSD deficiency by long-term steroid substitution.  J Steroid Biochem . 1989;  36(suppl) 174
  PubMedGoogle Scholar
• 135 Wolthers B G, de Vries J I, Volmer M, Nagel G T. Detection of 3β-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis.  Clin Chim Acta . 1987;  169 109-116
  CrossrefPubMedGoogle Scholar
• 136 McCartin S, Russell A J, Fisher R A. Phenotypic variability and origins of mutations in the gene encoding 3β-hydroxysteroid dehydrogenase type II.  J Mol Endocrinol . 2000;  24 75-82
  CrossrefPubMedGoogle Scholar
• 137 Chang Y T, Kulin H E, Garibaldi L. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.  J Clin Endocrinol Metab . 1993;  77 1251-1257
  CrossrefPubMedGoogle Scholar
• 138 Babalola G O, Shapiro B H. Changes in the expression of cytochrome P450c17 associated with ovarian cystic follicles: an immunocytochemical and enzymatic analysis of porcine ovaries.  J Steroid Biochem Mol Biol . 1992;  42 581-587
  CrossrefPubMedGoogle Scholar
• 139 Barnes R B, Ehrmann D A, Brigell D F, Rosenfield R L. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3β-hydroxy-delta 5-steroid dehydrogenase deficiency.  J Clin Endocrinol Metab . 1993;  76 450-455
  CrossrefPubMedGoogle Scholar
• 140 Barnes R B, Rosenfield R L, Burstein S, Ehrmann D A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.  N Engl J Med . 1989;  320 559-565
  PubMedGoogle Scholar
• 141 Paula F J, Dick-de-Paula I, Pontes A. Hyperandrogenism due to 3β-hydroxysteroid dehydrogenase deficiency with accessory adrenocortical tissue: a hormonal and metabolic evaluation.  Braz J Med Biol Res . 1994;  27 1149-1158
  PubMedGoogle Scholar